KK
CORT icon

KLP Kapitalforvaltning’s Corcept Therapeutics CORT Stock Holding History

KLP Kapitalforvaltning’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
21,700
+900
+4% +$54.3K 0.01% 808
2026
Q1 		$838K Buy
20,800
+600
+3% +$22.4K ﹤0.01% 1130
2025
Q4 		$703K Hold
20,200
– – ﹤0.01% 1232
2025
Q3 		$1.68M Buy
20,200
+800
+4% +$57.9K 0.01% 760
2025
Q2 		$1.42M Sell
19,400
-6,200
-24% -$450K 0.01% 805
2025
Q1 		$2.92M Sell
25,600
-1,000
-4% -$60.9K 0.01% 563
2024
Q4 		$1.34M Buy
+26,600
New +$1.39M 0.01% 842

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's CORT Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Corcept Therapeutics (CORT) stake by 4.3% in Q2 2026, buying an estimated $54.3K and bringing the position to 21,700 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #808.

KLP Kapitalforvaltning first reported a position in CORT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.92M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • KLP Kapitalforvaltning held 21,700 shares of Corcept Therapeutics worth $1.89M as of Q2 2026.
  • KLP Kapitalforvaltning bought 900 Corcept Therapeutics shares in Q2 2026, an estimated $54.3K.
  • Corcept Therapeutics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #808 holding.
  • KLP Kapitalforvaltning first reported a position in Corcept Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Corcept Therapeutics position peaked at $2.92M in Q1 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.